Related Experiment Video
Updated: Mar 9, 2026
Viability of Bioprinted Cellular Constructs Using a Three Dispenser Cartesian Printer
Published on: September 22, 2015
3D Bioprinting for Organ Regeneration.
Haitao Cui1, Margaret Nowicki1, John P Fisher2
1Department of Mechanical and Aerospace Engineering, Department of Biomedical Engineering, Department of Medicine, The George Washington University, 3590 Science and Engineering Hall, 800 22nd Street NW, Washington, DC, 20052, USA.
Three-dimensional (3D) bioprinting is revolutionizing regenerative medicine by enabling the creation of patient-specific tissues and organs. This advanced biomanufacturing technology offers precise control for engineering complex biological structures, addressing organ shortages.
Area of Science:
- Regenerative Medicine
- Biomanufacturing
- Tissue Engineering
Background:
- Regenerative medicine aims to engineer functional tissues/organs to address organ shortages and transplantation needs.
- Three-dimensional (3D) bioprinting is emerging as a key technology in this field.
- It offers patient-specific designs and precise manufacturing capabilities.
Purpose of the Study:
- To provide an overview of recent advances in 3D bioprinting technology.
- To discuss design concepts for bioinks used in 3D bioprinting.
- To highlight applications in engineering living organs.
Main Methods:
- Review of recent advancements in 3D bioprinting techniques.
- Analysis of bioink properties and design considerations.
- Focus on organ engineering applications including vasculature, neural networks, heart, and liver.
Main Results:
- 3D bioprinting allows precise control over composition, spatial distribution, and architectural complexity.
- This technology can effectively recapitulate the microstructure, architecture, mechanical properties, and biological functions of target tissues.
- Specific applications in engineering vascular networks, neural tissues, cardiac, and liver tissues were explored.
Conclusions:
- 3D bioprinting is a versatile tool for engineering complex living organs.
- Challenges remain in further developing the technology for clinical applications.
- Future perspectives focus on overcoming technical hurdles for advanced organ bioprinting.
